Clinical trial

Dose-response Study of Sodium Nitroprusside in Children Requiring Controlled…

NCT00135668 · The Emmes Company, LLC, Industry · Completed

Key facts

NCT number NCT00135668
Title Dose-response Study of Sodium Nitroprusside in Children Requiring Controlled Hypotension in the Operating Room
Official title A Phase 2 Multicenter, Randomized, Double-blind, Parallel Group, Dose-ranging, Effect-controlled Study to Determine the Pharmacokinetics and Pharmacodynamics of Sodium Nitroprusside in Pediatric Subjects
Lead sponsor The Emmes Company, LLC, Industry
Collaborators Stanford University Duke University
Status Completed
Phase Phase 2
Study type Interventional
Conditions Hypotension
Intervention type Drug
Interventions Nitroprusside
Enrollment 211
Start date Aug 1, 2005
Primary completion Mar 1, 2008
Completion Feb 1, 2009
First posted Aug 26, 2005
Last update posted Jan 2, 2024
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies